Rutgers University Study of the Genetics of Blood Cancers

ConditionsBlood Cancers Blood Cancer Leukemia Lymphoma Myeloma Hematologic Cancer Hematologic Malignancies Hematologic Neoplasm Hematologic Tumors

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-110

SponsorRutgers, The State University of New Jersey

About this trial

The goal of this study is to enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers.

Eligibility criteria

Qualifiers

age 18 years or older

currently living in the United States

have access to the internet and a computer, laptop, tablet or smartphone

willing to provide written informed consent for participation

Disqualifiers

Not able to meet or fulfill any of the inclusion criteria

Trial design

Treatments tested in this trial

Not listed

Trial groups

10,000 Participants

are grouped into 2 trial groups

Sponsors and collaborators

Rutgers, The State University of New Jersey

Lead sponsor

Source ClinicalTrials.gov